Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus) [Phase 2]
A Phase 2 trial evaluating bevacizumab in combination with everolimus for refractory metastatic renal cell carcinoma has been terminated, wi…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study of CNTO 328 in subjects with metastatic renal cell carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of ramucirumab in metastatic renal cell carcinoma completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity [Phase 2]
A Phase 2 trial evaluated heated chemotherapy delivered into the chest cavity for cancers that have spread to the pleura; the study is compl…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating Erlotinib and Cetuximab with or without Bevacizumab in patients with metastatic or unresectable k…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection [Phase 2]
Phase 2 clinical trial evaluating the reproducibility of 18F uptake in solid tumors using PET imaging after intravenous administration of a …
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Mechanisms of Anti-VEGF Induced Hypertension
This is a completed clinical trial update examining the mechanisms of hypertension induced by anti-VEGF therapy in renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) [Phase 1]
A Phase 1 clinical trial update for the V934/V935 cancer vaccine (V934-002) in selected solid tumors; the study is completed and results hav…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of RO4929097, a gamma-secretase/Notch pathway inhibitor, in combination with temsirolimus for advanced solid tumors has comple…
-
CLINICAL_TRIALS withdrawal · 2014-05-30Clinical Trial Update: Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment
Pfizer-sponsored trial evaluating axitinib in patients with advanced renal cell carcinoma after failure of first-line therapy has been withd…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer [Phase 2]
Phase 2 trial evaluating Axitinib (AG-013736) with and without dose titration in patients with renal cell carcinoma; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial comparing Tarceva plus Avastin versus Avastin alone in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Sunitinib Drug Levels and Outcomes in Kidney Cancer
This clinical trial update reports on the relationship between sunitinib drug levels and outcomes in renal cell carcinoma (kidney cancer).
-
CLINICAL_TRIALS research · 2014-05-14Clinical Trial Update: Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
A completed genome-wide association study aiming to identify genetic predictors of response to targeted therapy in hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer [Phase 2]
Phase 2 trial evaluating Bevacizumab plus Everolimus (RAD001) versus Bevacizumab with Interferon alfa-2a as first-line therapy for renal cel…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Sequential Study to Treat Renal Cell Carcinoma [Phase 3]
A Phase 3 clinical trial for renal cell carcinoma has completed.
-
CLINICAL_TRIALS safety_alert · 2014-04-21Clinical Trial Update: Hepatic Monitoring for Pazopanib
Safety update on Pazopanib for renal cell carcinoma focusing on hepatic monitoring requirements. The document outlines liver function monito…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors [Phase 1]
Phase 1 dose-escalation study of TH-302 in combination with sunitinib for advanced renal cell carcinoma, gastrointestinal stromal tumors, an…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody [Phase 3]
Phase 3 trial for pre-surgical detection of clear cell renal cell carcinoma using radiolabeled G250-antibody has completed with results post…
-
FDA approval · 2014-04-07FDA Approved: TORISEL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Torisel (temsirolimus) from Wyeth Pharmaceuticals (a Pfizer unit).
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies [Phase 1]
A Phase 1 clinical trial evaluating the combination of sunitinib malate and bevacizumab in kidney cancer and other solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating erlotinib (OSI-774) in combination with bevacizumab for metastatic renal cell carcinoma has completed. The update s…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma [Phase 1]
Phase 1 study evaluating GC1008 (fresolimumab), a TGF-beta antagonist, for safety and preliminary efficacy in renal cell carcinoma and malig…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Pazopanib in Second-line Therapy in Renal Cell Carcinoma [Phase 2]
A Phase 2 trial update evaluating pazopanib as second-line therapy for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus peripheral stem cell transplantation in melanoma or metastatic kidney cancer has complet…